Perrigo Company PLC (NYSE:PRGO) has been assigned an average recommendation of “Hold” from the nine analysts that are presently covering the company, MarketBeat.com reports. Five analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $54.17.
A number of analysts have recently issued reports on PRGO shares. Wells Fargo & Co lifted their price objective on shares of Perrigo from $45.00 to $52.00 and gave the stock a “market perform” rating in a report on Monday, September 30th. Argus raised shares of Perrigo from a “hold” rating to a “buy” rating in a report on Friday, October 11th. SunTrust Banks lifted their price objective on shares of Perrigo from $51.00 to $55.00 and gave the stock a “hold” rating in a report on Wednesday, September 25th. They noted that the move was a valuation call. ValuEngine raised shares of Perrigo from a “sell” rating to a “hold” rating in a report on Wednesday, September 11th. Finally, TheStreet raised shares of Perrigo from a “d+” rating to a “c-” rating in a report on Friday, September 27th.
In other Perrigo news, EVP Grainne Quinn sold 2,050 shares of the business’s stock in a transaction on Monday, November 11th. The shares were sold at an average price of $49.08, for a total value of $100,614.00. Following the completion of the sale, the executive vice president now directly owns 3,047 shares of the company’s stock, valued at $149,546.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Ronald Winowiecki sold 826 shares of the business’s stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $48.03, for a total transaction of $39,672.78. Following the completion of the sale, the chief financial officer now directly owns 6,952 shares of the company’s stock, valued at $333,904.56. The disclosure for this sale can be found here. Insiders sold 5,300 shares of company stock valued at $261,244 over the last three months. 7.70% of the stock is currently owned by insiders.
Shares of NYSE PRGO traded up $1.34 during mid-day trading on Thursday, reaching $49.38. 1,069,432 shares of the company were exchanged, compared to its average volume of 1,030,461. Perrigo has a 52 week low of $36.28 and a 52 week high of $64.63. The company has a quick ratio of 1.32, a current ratio of 2.07 and a debt-to-equity ratio of 0.58. The stock has a market capitalization of $6.54 billion, a PE ratio of 10.85, a PEG ratio of 4.85 and a beta of 1.46. The company’s 50 day moving average price is $53.09 and its 200 day moving average price is $49.97.
Perrigo (NYSE:PRGO) last posted its quarterly earnings data on Wednesday, November 6th. The company reported $1.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.93 by $0.11. Perrigo had a net margin of 5.24% and a return on equity of 9.39%. The company had revenue of $1.19 billion during the quarter, compared to the consensus estimate of $1.20 billion. During the same period in the previous year, the firm posted $1.09 EPS. The firm’s revenue was up 5.1% compared to the same quarter last year. On average, sell-side analysts predict that Perrigo will post 3.96 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Friday, November 29th will be paid a $0.21 dividend. This represents a $0.84 annualized dividend and a yield of 1.70%. The ex-dividend date of this dividend is Wednesday, November 27th. Perrigo’s dividend payout ratio is presently 18.46%.
Perrigo Company Profile
Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.
Further Reading: Stock Symbols Definition, Examples, Lookup
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.